Intentions to use pre-exposure prophylaxis among current phase 2B preventive HIV-1 vaccine efficacy trial participants

In November 2010, the iPrEx study reported that pre-exposure prophylaxis (PrEP) with daily tenofovir disoproxil fumarate/emtricitabine reduced HIV infections by 44% among men who have sex with men and subsequent trials corroborated efficacy among heterosexual men and women. During regularly schedule...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Fuchs, Jonathan D., Sobieszczyk, Magdalena E., Madenwald, Tamra, Grove, Doug, Karuna, Shelly T., Andrasik, Michele, Sherwat, Adam, Broder, Gail, Mayer, Kenneth, Koblin, Beryl, Hammer, Scott
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3714219/
https://ncbi.nlm.nih.gov/pubmed/23614998
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0b013e318296df94
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados